Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant vs Urinary HCG for Ovulation Triggering in IVF
NCT00954265Phase 3Unknown
- Sponsor
- UZ Brussel
- Start
- Aug 2005
- Primary completion
- Dec 2007
- Modality
- rProtein (Recombinant Protein), Hormone, Biologic
- Countries
- 1
01
Overview
Phase 3, randomised trial of recombinant human chorionic gonadotrophin in infertility (2 arms), sponsored by UZ Brussel. Primary endpoint: Blastulation rate at Day 5. Status: unknown.
02
Drugs
recombinant human chorionic gonadotrophin
03
Conditions
infertility
Beyond the preview
Go deeper on NCT00954265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00954265.